Medacta Group S.A.
MEDGFOTCHealthcare
$83.91
+$0.00(+0.00%)
Market Cap$1.7B
P/E Ratio—
52W High$83.91
52W Low$83.91
Medacta Group S.A. (MEDGF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MEDGF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.69B | $0.59B | $0.51B | $0.44B | $0.36B |
| Cost of Revenue | $0.25B | $0.19B | $0.16B | $0.13B | $0.10B |
| Gross Profit | $0.44B | $0.40B | $0.35B | $0.31B | $0.26B |
| Gross Margin %(computed) | 64.13% | 67.64% | 68.10% | 69.83% | 71.94% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.02B | $0.02B | $0.02B | $0.01B |
| G&A Expenses | $0.00B | $0.02B | $0.07B | $0.06B | $0.05B |
| Total Operating Expenses | $0.33B | $0.31B | $0.27B | $0.24B | $0.20B |
| Operating Income | $0.12B | $0.09B | $0.07B | $0.06B | $0.06B |
| Operating Margin %(computed) | 16.80% | 15.38% | 14.57% | 14.06% | 16.19% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.12B | $0.09B | $0.06B | $0.05B | $0.06B |
| Income Tax Expense | $0.02B | $0.01B | $0.01B | $0.01B | $0.00B |
| Net Income | $0.10B | $0.07B | $0.05B | $0.05B | $0.05B |
| Net Margin %(computed) | 13.97% | 12.34% | 9.27% | 10.58% | 14.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $4.81 | $3.66 | $2.37 | $2.32 | $2.58 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.19B | $0.16B | $0.12B | $0.11B | $0.10B |
| EBITDA Margin %(computed) | 27.69% | 27.18% | 23.42% | 24.47% | 26.94% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · EUR · B
Explore more Medacta Group S.A. data
About Medacta Group S.A. (MEDGF) Income Statement
Medacta Group S.A. (MEDGF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MEDGF reported revenue of $0.69B, gross profit of $0.44B (gross margin 64.13%), and net income of $0.10B — a net profit margin of 13.97%.
Frequently asked questions
MEDGF · 4 questionsMedacta Group S.A. (MEDGF) reported revenue of $0.69B for 2025, up 16.5% year-over-year.
MEDGF revenueMEDGF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09